Pharmacia
E411219
Pharmacia was a major pharmaceutical company known for its global drug development and manufacturing operations before ultimately becoming part of Pfizer.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Pharmacia & Upjohn | 4 |
| Pharmacia canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T4069989 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Pharmacia Context triple: [G. D. Searle & Company, mergedInto, Pharmacia]
-
A.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
B.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
C.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
D.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Pharmacia Target entity description: Pharmacia was a major pharmaceutical company known for its global drug development and manufacturing operations before ultimately becoming part of Pfizer.
-
A.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
B.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
C.
AstraZeneca
AstraZeneca is a global biopharmaceutical company known for researching, developing, and manufacturing prescription medicines across areas such as oncology, cardiovascular, respiratory, and immunology.
-
D.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf | pharmaceutical company ⓘ |
| acquiredBy |
Monsanto Company
ⓘ
Pfizer ⓘ |
| acquisitionYearByMonsanto | 2000 ⓘ |
| acquisitionYearByPfizer | 2003 ⓘ |
| activity |
drug development
ⓘ
drug manufacturing ⓘ global pharmaceutical marketing ⓘ |
| collaboratedWith |
Amgen
ⓘ
Biotech firms in Scandinavia ⓘ Pfizer ⓘ |
| corporateForm | public company ⓘ |
| country | Sweden ⓘ |
| dissolvedIn | 2003 ⓘ |
| foundedIn | 1911 ⓘ |
| founder | Gustav Felix Grönfeldt ⓘ |
| headquartersCountry | Sweden ⓘ |
| headquartersLocation | Uppsala ⓘ |
| industry |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| knownFor |
biotechnology-based medicines
ⓘ
global drug development ⓘ innovative ophthalmic treatments ⓘ |
| languageOfName | Latin ⓘ |
| listedOn |
New York Stock Exchange
ⓘ
Nasdaq Stockholm ⓘ
surface form:
Stockholm Stock Exchange
|
| mergedInYear | 1995 ⓘ |
| mergedWith |
Upjohn Company
ⓘ
surface form:
Upjohn
|
| mergerFormedEntity |
Pharmacia
self-linksurface differs
ⓘ
surface form:
Pharmacia & Upjohn
|
| nameMeaning | pharmacy ⓘ |
| notableProduct |
Fragmin
ⓘ
Genotropin ⓘ Xalatan ⓘ |
| notableSubsidiary |
Pharmacia
self-linksurface differs
ⓘ
surface form:
Pharmacia & Upjohn
|
| operatedIn |
Asia
ⓘ
Europe ⓘ North America ⓘ |
| parentCompany | Pfizer ⓘ |
| regulatoryRegion |
European Union
ⓘ
United States of America ⓘ
surface form:
United States
|
| researchFocus |
cancer
ⓘ
cardiovascular diseases ⓘ hormonal disorders ⓘ |
| specialization |
endocrinology drugs
ⓘ
oncology drugs ⓘ ophthalmology drugs ⓘ |
| status | defunct ⓘ |
| successor |
Pharmacia
self-linksurface differs
ⓘ
surface form:
Pharmacia & Upjohn
|
| therapeuticArea |
endocrinology
ⓘ
oncology ⓘ ophthalmology ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Pharmacia Description of subject: Pharmacia was a major pharmaceutical company known for its global drug development and manufacturing operations before ultimately becoming part of Pfizer.
Referenced by (5)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Pharmacia & Upjohn
this entity surface form:
Pharmacia & Upjohn
this entity surface form:
Pharmacia & Upjohn
this entity surface form:
Pharmacia & Upjohn